nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—CYP19A1—Paclitaxel—ovarian cancer	0.227	1	CbGbCtD
Cyproterone acetate—CYP19A1—follicular fluid—ovarian cancer	0.0727	0.306	CbGeAlD
Cyproterone acetate—CYP19A1—corpus luteum—ovarian cancer	0.0419	0.177	CbGeAlD
Cyproterone acetate—CYP19A1—ovarian follicle—ovarian cancer	0.0328	0.138	CbGeAlD
Cyproterone acetate—AR—oviduct—ovarian cancer	0.0127	0.0537	CbGeAlD
Cyproterone acetate—Ethynodiol—PGR—ovarian cancer	0.00437	0.308	CrCbGaD
Cyproterone acetate—AR—myometrium—ovarian cancer	0.00408	0.0172	CbGeAlD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.00371	0.0282	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—INHA—ovarian cancer	0.00361	0.0274	CbGpPWpGaD
Cyproterone acetate—CYP19A1—endometrium—ovarian cancer	0.00324	0.0137	CbGeAlD
Cyproterone acetate—AR—epithelium—ovarian cancer	0.0032	0.0135	CbGeAlD
Cyproterone acetate—Megestrol acetate—PGR—ovarian cancer	0.00319	0.225	CrCbGaD
Cyproterone acetate—AR—uterine cervix—ovarian cancer	0.00317	0.0134	CbGeAlD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AREG—ovarian cancer	0.00306	0.0232	CbGpPWpGaD
Cyproterone acetate—AR—decidua—ovarian cancer	0.00302	0.0127	CbGeAlD
Cyproterone acetate—CYP19A1—gonad—ovarian cancer	0.00301	0.0127	CbGeAlD
Cyproterone acetate—CYP19A1—uterus—ovarian cancer	0.00299	0.0126	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00297	0.0226	CbGpPWpGaD
Cyproterone acetate—NR3C1—myometrium—ovarian cancer	0.00295	0.0124	CbGeAlD
Cyproterone acetate—AR—endometrium—ovarian cancer	0.00287	0.0121	CbGeAlD
Cyproterone acetate—NR3C1—Nuclear Receptors—NR5A1—ovarian cancer	0.00285	0.0217	CbGpPWpGaD
Cyproterone acetate—NR3C1—embryo—ovarian cancer	0.00284	0.012	CbGeAlD
Cyproterone acetate—Ethynodiol—ESR1—ovarian cancer	0.00276	0.194	CrCbGaD
Cyproterone acetate—CYP19A1—female reproductive system—ovarian cancer	0.00269	0.0113	CbGeAlD
Cyproterone acetate—AR—gonad—ovarian cancer	0.00266	0.0112	CbGeAlD
Cyproterone acetate—AR—uterus—ovarian cancer	0.00265	0.0111	CbGeAlD
Cyproterone acetate—CYP19A1—female gonad—ovarian cancer	0.00244	0.0103	CbGeAlD
Cyproterone acetate—AR—female reproductive system—ovarian cancer	0.00238	0.01	CbGeAlD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—BCL9—ovarian cancer	0.00237	0.018	CbGpPWpGaD
Cyproterone acetate—NR3C1—epithelium—ovarian cancer	0.00232	0.00977	CbGeAlD
Cyproterone acetate—NR3C1—uterine cervix—ovarian cancer	0.0023	0.00969	CbGeAlD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00225	0.0171	CbGpPWpGaD
Cyproterone acetate—NR3C1—decidua—ovarian cancer	0.00219	0.00923	CbGeAlD
Cyproterone acetate—CYP19A1—testis—ovarian cancer	0.00217	0.00914	CbGeAlD
Cyproterone acetate—AR—female gonad—ovarian cancer	0.00216	0.00912	CbGeAlD
Cyproterone acetate—AR—vagina—ovarian cancer	0.00215	0.00906	CbGeAlD
Cyproterone acetate—NR3C1—endometrium—ovarian cancer	0.00208	0.00876	CbGeAlD
Cyproterone acetate—CYP19A1—Endogenous sterols—CYP1B1—ovarian cancer	0.00205	0.0156	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—MLH1—ovarian cancer	0.00195	0.0148	CbGpPWpGaD
Cyproterone acetate—NR3C1—gonad—ovarian cancer	0.00193	0.00813	CbGeAlD
Cyproterone acetate—AR—testis—ovarian cancer	0.00192	0.00809	CbGeAlD
Cyproterone acetate—NR3C1—uterus—ovarian cancer	0.00192	0.00807	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptors—PGR—ovarian cancer	0.00187	0.0142	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—PGR—ovarian cancer	0.00186	0.131	CrCbGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—PGR—ovarian cancer	0.00185	0.0141	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—ovarian cancer	0.00184	0.014	CbGpPWpGaD
Cyproterone acetate—NR3C1—female reproductive system—ovarian cancer	0.00172	0.00726	CbGeAlD
Cyproterone acetate—NR3C1—bone marrow—ovarian cancer	0.00163	0.00685	CbGeAlD
Cyproterone acetate—CYP19A1—lymph node—ovarian cancer	0.00157	0.00662	CbGeAlD
Cyproterone acetate—NR3C1—female gonad—ovarian cancer	0.00157	0.0066	CbGeAlD
Cyproterone acetate—NR3C1—vagina—ovarian cancer	0.00156	0.00656	CbGeAlD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00148	0.0112	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—CCND2—ovarian cancer	0.00148	0.0112	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—PARP1—ovarian cancer	0.00147	0.0112	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PGR—ovarian cancer	0.00142	0.0108	CbGpPWpGaD
Cyproterone acetate—AR—lymph node—ovarian cancer	0.00139	0.00586	CbGeAlD
Cyproterone acetate—NR3C1—testis—ovarian cancer	0.00139	0.00586	CbGeAlD
Cyproterone acetate—AR—FOXA1 transcription factor network—BRCA1—ovarian cancer	0.00133	0.0101	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00133	0.0101	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—HNF1B—ovarian cancer	0.00132	0.01	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—SOD1—ovarian cancer	0.00126	0.00959	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.00123	0.00937	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.00119	0.00902	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP1B1—ovarian cancer	0.00118	0.00894	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—ovarian cancer	0.00117	0.0826	CrCbGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00114	0.00867	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SMARCA4—ovarian cancer	0.00113	0.00858	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00112	0.00853	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—BRCA1—ovarian cancer	0.00103	0.00779	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ATF3—ovarian cancer	0.00101	0.00769	CbGpPWpGaD
Cyproterone acetate—NR3C1—lymph node—ovarian cancer	0.00101	0.00425	CbGeAlD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.00101	0.00764	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—ESR1—ovarian cancer	0.001	0.0076	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000951	0.00723	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000938	0.00713	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.000901	0.00685	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—ESR1—ovarian cancer	0.000889	0.00676	CbGpPWpGaD
Cyproterone acetate—Megestrol acetate—ABCB1—ovarian cancer	0.000857	0.0603	CrCbGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—ovarian cancer	0.00084	0.00638	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—RBL2—ovarian cancer	0.000833	0.00633	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ovarian cancer	0.000825	0.00627	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MTOR—ovarian cancer	0.000819	0.00623	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00079	0.00601	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000771	0.00586	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR1—ovarian cancer	0.000759	0.00577	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—ovarian cancer	0.000759	0.00577	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—BRCA1—ovarian cancer	0.000758	0.00576	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.000727	0.00552	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—ovarian cancer	0.000706	0.00537	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.000679	0.00516	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—ovarian cancer	0.000672	0.00511	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—CDKN1B—ovarian cancer	0.000671	0.0051	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCNE1—ovarian cancer	0.000664	0.00504	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—MAPK3—ovarian cancer	0.000629	0.00478	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.000625	0.00475	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—ovarian cancer	0.000619	0.0047	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MAPK3—ovarian cancer	0.000605	0.0046	CbGpPWpGaD
Cyproterone acetate—AR—FOXA1 transcription factor network—CDKN1B—ovarian cancer	0.000605	0.00459	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.0006	0.00456	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—MAPK1—ovarian cancer	0.000599	0.00455	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.000584	0.00444	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.00058	0.00441	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MAPK1—ovarian cancer	0.000576	0.00437	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CDKN1B—ovarian cancer	0.000573	0.00436	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.000546	0.00415	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.00053	0.00403	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CAV1—ovarian cancer	0.000525	0.00399	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—ovarian cancer	0.000521	0.00396	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PIK3CA—ovarian cancer	0.00052	0.00395	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000513	0.0039	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000499	0.00379	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000497	0.00377	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—GADD45A—ovarian cancer	0.000496	0.00377	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—HRAS—ovarian cancer	0.000481	0.00365	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.00048	0.00365	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ovarian cancer	0.00048	0.00364	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—ovarian cancer	0.000472	0.00359	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ESR1—ovarian cancer	0.000465	0.00354	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—ovarian cancer	0.000462	0.00351	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—ovarian cancer	0.000459	0.00349	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000456	0.00346	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—APC—ovarian cancer	0.00045	0.00342	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000449	0.00341	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CCND1—ovarian cancer	0.000444	0.00337	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—ovarian cancer	0.00044	0.00334	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000439	0.00334	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000427	0.00325	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—ovarian cancer	0.000425	0.00323	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.000414	0.00315	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000411	0.00313	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP1B1—ovarian cancer	0.000409	0.00311	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—ovarian cancer	0.000408	0.0031	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000404	0.00307	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NR5A1—ovarian cancer	0.000389	0.00296	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000386	0.00294	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ovarian cancer	0.000384	0.00292	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000372	0.00283	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Docetaxel—ovarian cancer	0.00037	0.000948	CcSEcCtD
Cyproterone acetate—Vomiting—Topotecan—ovarian cancer	0.000366	0.00094	CcSEcCtD
Cyproterone acetate—Malaise—Paclitaxel—ovarian cancer	0.000366	0.00094	CcSEcCtD
Cyproterone acetate—Cardiac failure—Doxorubicin—ovarian cancer	0.000366	0.000938	CcSEcCtD
Cyproterone acetate—Mood swings—Epirubicin—ovarian cancer	0.000365	0.000937	CcSEcCtD
Cyproterone acetate—Syncope—Paclitaxel—ovarian cancer	0.000364	0.000935	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000364	0.000934	CcSEcCtD
Cyproterone acetate—Leukopenia—Paclitaxel—ovarian cancer	0.000364	0.000933	CcSEcCtD
Cyproterone acetate—Rash—Topotecan—ovarian cancer	0.000363	0.000932	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Vinorelbine—ovarian cancer	0.000363	0.000932	CcSEcCtD
Cyproterone acetate—Dermatitis—Topotecan—ovarian cancer	0.000363	0.000931	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Epirubicin—ovarian cancer	0.000361	0.000927	CcSEcCtD
Cyproterone acetate—Headache—Topotecan—ovarian cancer	0.000361	0.000926	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.00036	0.00274	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.00036	0.00274	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Docetaxel—ovarian cancer	0.000359	0.000921	CcSEcCtD
Cyproterone acetate—Vomiting—Melphalan—ovarian cancer	0.000359	0.00092	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ovarian cancer	0.000357	0.00272	CbGpPWpGaD
Cyproterone acetate—Immune system disorder—Docetaxel—ovarian cancer	0.000357	0.000917	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Paclitaxel—ovarian cancer	0.000357	0.000916	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Docetaxel—ovarian cancer	0.000356	0.000915	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Epirubicin—ovarian cancer	0.000356	0.000914	CcSEcCtD
Cyproterone acetate—Rash—Melphalan—ovarian cancer	0.000356	0.000913	CcSEcCtD
Cyproterone acetate—Dermatitis—Melphalan—ovarian cancer	0.000355	0.000912	CcSEcCtD
Cyproterone acetate—Chills—Docetaxel—ovarian cancer	0.000355	0.000911	CcSEcCtD
Cyproterone acetate—Cough—Paclitaxel—ovarian cancer	0.000354	0.00091	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—ovarian cancer	0.000354	0.00269	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000354	0.00269	CbGpPWpGaD
Cyproterone acetate—Asthenia—Vinorelbine—ovarian cancer	0.000354	0.000907	CcSEcCtD
Cyproterone acetate—Migraine—Doxorubicin—ovarian cancer	0.000351	0.000901	CcSEcCtD
Cyproterone acetate—Affect lability—Doxorubicin—ovarian cancer	0.000351	0.000901	CcSEcCtD
Cyproterone acetate—Alopecia—Docetaxel—ovarian cancer	0.000349	0.000897	CcSEcCtD
Cyproterone acetate—Pruritus—Vinorelbine—ovarian cancer	0.000349	0.000895	CcSEcCtD
Cyproterone acetate—Breast disorder—Epirubicin—ovarian cancer	0.000348	0.000894	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000347	0.000891	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ovarian cancer	0.000347	0.00264	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—WDR77—ovarian cancer	0.000347	0.00264	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Docetaxel—ovarian cancer	0.000346	0.000889	CcSEcCtD
Cyproterone acetate—Malnutrition—Docetaxel—ovarian cancer	0.000344	0.000883	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000343	0.000881	CcSEcCtD
Cyproterone acetate—Nausea—Topotecan—ovarian cancer	0.000342	0.000878	CcSEcCtD
Cyproterone acetate—Discomfort—Paclitaxel—ovarian cancer	0.000342	0.000877	CcSEcCtD
Cyproterone acetate—Muscular weakness—Epirubicin—ovarian cancer	0.00034	0.000873	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00034	0.000873	CcSEcCtD
Cyproterone acetate—Mood swings—Doxorubicin—ovarian cancer	0.000338	0.000867	CcSEcCtD
Cyproterone acetate—Diarrhoea—Vinorelbine—ovarian cancer	0.000337	0.000865	CcSEcCtD
Cyproterone acetate—Nausea—Melphalan—ovarian cancer	0.000335	0.00086	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000334	0.000858	CcSEcCtD
Cyproterone acetate—Asthma—Epirubicin—ovarian cancer	0.000333	0.000855	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000332	0.00252	CbGpPWpGaD
Cyproterone acetate—Oedema—Paclitaxel—ovarian cancer	0.000331	0.000851	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000329	0.000845	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—ovarian cancer	0.000328	0.00249	CbGpPWpGaD
Cyproterone acetate—Pancreatitis—Epirubicin—ovarian cancer	0.000327	0.000838	CcSEcCtD
Cyproterone acetate—Shock—Paclitaxel—ovarian cancer	0.000326	0.000837	CcSEcCtD
Cyproterone acetate—Dizziness—Vinorelbine—ovarian cancer	0.000326	0.000836	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Paclitaxel—ovarian cancer	0.000325	0.000834	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—ovarian cancer	0.000325	0.00247	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000325	0.000833	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—ovarian cancer	0.000324	0.00246	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Paclitaxel—ovarian cancer	0.000324	0.00083	CcSEcCtD
Cyproterone acetate—Breast disorder—Doxorubicin—ovarian cancer	0.000322	0.000827	CcSEcCtD
Cyproterone acetate—Skin disorder—Paclitaxel—ovarian cancer	0.000322	0.000826	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000321	0.000824	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00032	0.000822	CcSEcCtD
Cyproterone acetate—Anaemia—Docetaxel—ovarian cancer	0.000318	0.000817	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—ovarian cancer	0.000317	0.00241	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN1B—ovarian cancer	0.000316	0.0024	CbGpPWpGaD
Cyproterone acetate—Anorexia—Paclitaxel—ovarian cancer	0.000316	0.000811	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000316	0.0024	CbGpPWpGaD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000315	0.000808	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—ovarian cancer	0.000315	0.000808	CcSEcCtD
Cyproterone acetate—Vomiting—Vinorelbine—ovarian cancer	0.000313	0.000804	CcSEcCtD
Cyproterone acetate—Rash—Vinorelbine—ovarian cancer	0.000311	0.000797	CcSEcCtD
Cyproterone acetate—Dermatitis—Vinorelbine—ovarian cancer	0.00031	0.000797	CcSEcCtD
Cyproterone acetate—Hypotension—Paclitaxel—ovarian cancer	0.00031	0.000795	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—ovarian cancer	0.00031	0.00235	CbGpPWpGaD
Cyproterone acetate—Headache—Vinorelbine—ovarian cancer	0.000309	0.000792	CcSEcCtD
Cyproterone acetate—Syncope—Docetaxel—ovarian cancer	0.000309	0.000792	CcSEcCtD
Cyproterone acetate—Asthma—Doxorubicin—ovarian cancer	0.000308	0.000791	CcSEcCtD
Cyproterone acetate—Leukopenia—Docetaxel—ovarian cancer	0.000308	0.000791	CcSEcCtD
Cyproterone acetate—Pollakiuria—Epirubicin—ovarian cancer	0.000308	0.00079	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—ovarian cancer	0.000306	0.00232	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000304	0.000781	CcSEcCtD
Cyproterone acetate—Weight increased—Epirubicin—ovarian cancer	0.000303	0.000778	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Docetaxel—ovarian cancer	0.000303	0.000777	CcSEcCtD
Cyproterone acetate—Pancreatitis—Doxorubicin—ovarian cancer	0.000302	0.000776	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—ovarian cancer	0.000302	0.00229	CbGpPWpGaD
Cyproterone acetate—Weight decreased—Epirubicin—ovarian cancer	0.000302	0.000774	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Epirubicin—ovarian cancer	0.000301	0.000771	CcSEcCtD
Cyproterone acetate—Cough—Docetaxel—ovarian cancer	0.0003	0.000771	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—ovarian cancer	0.000299	0.00227	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Paclitaxel—ovarian cancer	0.000296	0.000758	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—ovarian cancer	0.000293	0.00223	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000293	0.00222	CbGpPWpGaD
Cyproterone acetate—Nausea—Vinorelbine—ovarian cancer	0.000293	0.000751	CcSEcCtD
Cyproterone acetate—Renal failure—Epirubicin—ovarian cancer	0.000292	0.00075	CcSEcCtD
Cyproterone acetate—Dyspepsia—Paclitaxel—ovarian cancer	0.000292	0.000749	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—ovarian cancer	0.000291	0.00221	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000291	0.000747	CcSEcCtD
Cyproterone acetate—Jaundice—Epirubicin—ovarian cancer	0.00029	0.000743	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000289	0.00219	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Paclitaxel—ovarian cancer	0.000288	0.000739	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ovarian cancer	0.000287	0.00218	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000286	0.000734	CcSEcCtD
Cyproterone acetate—Fatigue—Paclitaxel—ovarian cancer	0.000286	0.000733	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—ovarian cancer	0.000285	0.00217	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000285	0.00217	CbGpPWpGaD
Cyproterone acetate—Sweating—Epirubicin—ovarian cancer	0.000285	0.000731	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—ovarian cancer	0.000285	0.000731	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000284	0.00216	CbGpPWpGaD
Cyproterone acetate—Constipation—Paclitaxel—ovarian cancer	0.000283	0.000727	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—ovarian cancer	0.000283	0.00215	CbGpPWpGaD
Cyproterone acetate—Haematuria—Epirubicin—ovarian cancer	0.000283	0.000727	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000281	0.000722	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000281	0.000721	CcSEcCtD
Cyproterone acetate—Oedema—Docetaxel—ovarian cancer	0.000281	0.000721	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—ovarian cancer	0.000281	0.00072	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IL6ST—ovarian cancer	0.000279	0.00212	CbGpPWpGaD
Cyproterone acetate—Weight decreased—Doxorubicin—ovarian cancer	0.000279	0.000716	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000278	0.000714	CcSEcCtD
Cyproterone acetate—Shock—Docetaxel—ovarian cancer	0.000276	0.000709	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Docetaxel—ovarian cancer	0.000276	0.000707	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Docetaxel—ovarian cancer	0.000275	0.000706	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000275	0.00209	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Docetaxel—ovarian cancer	0.000274	0.000704	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Paclitaxel—ovarian cancer	0.000273	0.000701	CcSEcCtD
Cyproterone acetate—Skin disorder—Docetaxel—ovarian cancer	0.000273	0.0007	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—ovarian cancer	0.000273	0.00207	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TTF1—ovarian cancer	0.000272	0.00207	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000271	0.000696	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—ovarian cancer	0.00027	0.000694	CcSEcCtD
Cyproterone acetate—Haemoglobin—Epirubicin—ovarian cancer	0.000268	0.000688	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—ovarian cancer	0.000268	0.000688	CcSEcCtD
Cyproterone acetate—Anorexia—Docetaxel—ovarian cancer	0.000268	0.000687	CcSEcCtD
Cyproterone acetate—Haemorrhage—Epirubicin—ovarian cancer	0.000267	0.000685	CcSEcCtD
Cyproterone acetate—Hepatitis—Epirubicin—ovarian cancer	0.000267	0.000685	CcSEcCtD
Cyproterone acetate—Sweating—Doxorubicin—ovarian cancer	0.000264	0.000676	CcSEcCtD
Cyproterone acetate—Urticaria—Paclitaxel—ovarian cancer	0.000263	0.000676	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—WDR77—ovarian cancer	0.000263	0.002	CbGpPWpGaD
Cyproterone acetate—Hypotension—Docetaxel—ovarian cancer	0.000263	0.000674	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—ovarian cancer	0.000262	0.000673	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Epirubicin—ovarian cancer	0.000262	0.000673	CcSEcCtD
Cyproterone acetate—Body temperature increased—Paclitaxel—ovarian cancer	0.000262	0.000672	CcSEcCtD
Cyproterone acetate—Abdominal pain—Paclitaxel—ovarian cancer	0.000262	0.000672	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00026	0.000667	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.00026	0.00197	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—ovarian cancer	0.000258	0.00196	CbGpPWpGaD
Cyproterone acetate—Visual impairment—Epirubicin—ovarian cancer	0.000257	0.00066	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—PGR—ovarian cancer	0.000256	0.00194	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Epirubicin—ovarian cancer	0.000252	0.000647	CcSEcCtD
Cyproterone acetate—Dyspnoea—Docetaxel—ovarian cancer	0.00025	0.000643	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NME2—ovarian cancer	0.00025	0.0019	CbGpPWpGaD
Cyproterone acetate—Eye disorder—Epirubicin—ovarian cancer	0.000249	0.00064	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000248	0.00189	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Doxorubicin—ovarian cancer	0.000248	0.000637	CcSEcCtD
Cyproterone acetate—Dyspepsia—Docetaxel—ovarian cancer	0.000247	0.000635	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NR5A1—ovarian cancer	0.000247	0.00188	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—ovarian cancer	0.000247	0.00188	CbGpPWpGaD
Cyproterone acetate—Haemorrhage—Doxorubicin—ovarian cancer	0.000247	0.000633	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—ovarian cancer	0.000247	0.000633	CcSEcCtD
Cyproterone acetate—Decreased appetite—Docetaxel—ovarian cancer	0.000244	0.000627	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000244	0.000627	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000243	0.00185	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000243	0.000622	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000243	0.000622	CcSEcCtD
Cyproterone acetate—Fatigue—Docetaxel—ovarian cancer	0.000242	0.000622	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—ovarian cancer	0.000242	0.00184	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Epirubicin—ovarian cancer	0.000242	0.000621	CcSEcCtD
Cyproterone acetate—Immune system disorder—Epirubicin—ovarian cancer	0.000241	0.000618	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Epirubicin—ovarian cancer	0.00024	0.000617	CcSEcCtD
Cyproterone acetate—Constipation—Docetaxel—ovarian cancer	0.00024	0.000617	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.00024	0.00183	CbGpPWpGaD
Cyproterone acetate—Chills—Epirubicin—ovarian cancer	0.000239	0.000614	CcSEcCtD
Cyproterone acetate—Visual impairment—Doxorubicin—ovarian cancer	0.000238	0.00061	CcSEcCtD
Cyproterone acetate—Asthenia—Paclitaxel—ovarian cancer	0.000238	0.00061	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000238	0.00181	CbGpPWpGaD
Cyproterone acetate—Alopecia—Epirubicin—ovarian cancer	0.000236	0.000605	CcSEcCtD
Cyproterone acetate—Pruritus—Paclitaxel—ovarian cancer	0.000235	0.000602	CcSEcCtD
Cyproterone acetate—Mental disorder—Epirubicin—ovarian cancer	0.000234	0.0006	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—ovarian cancer	0.000233	0.000599	CcSEcCtD
Cyproterone acetate—Malnutrition—Epirubicin—ovarian cancer	0.000232	0.000596	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Docetaxel—ovarian cancer	0.000232	0.000594	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—ovarian cancer	0.000231	0.000592	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00023	0.00059	CcSEcCtD
Cyproterone acetate—Tension—Epirubicin—ovarian cancer	0.000228	0.000585	CcSEcCtD
Cyproterone acetate—Diarrhoea—Paclitaxel—ovarian cancer	0.000227	0.000582	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000225	0.00171	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Doxorubicin—ovarian cancer	0.000224	0.000575	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—ovarian cancer	0.000223	0.000572	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000222	0.000571	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—YAP1—ovarian cancer	0.000222	0.00169	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Docetaxel—ovarian cancer	0.000222	0.00057	CcSEcCtD
Cyproterone acetate—Body temperature increased—Docetaxel—ovarian cancer	0.000222	0.00057	CcSEcCtD
Cyproterone acetate—Chills—Doxorubicin—ovarian cancer	0.000221	0.000568	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000221	0.00168	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—ovarian cancer	0.000219	0.00167	CbGpPWpGaD
Cyproterone acetate—Dizziness—Paclitaxel—ovarian cancer	0.000219	0.000563	CcSEcCtD
Cyproterone acetate—Alopecia—Doxorubicin—ovarian cancer	0.000218	0.00056	CcSEcCtD
Cyproterone acetate—Mental disorder—Doxorubicin—ovarian cancer	0.000216	0.000555	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Epirubicin—ovarian cancer	0.000215	0.000553	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000215	0.00164	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000215	0.00164	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000215	0.00163	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Doxorubicin—ovarian cancer	0.000215	0.000551	CcSEcCtD
Cyproterone acetate—Anaemia—Epirubicin—ovarian cancer	0.000215	0.000551	CcSEcCtD
Cyproterone acetate—Agitation—Epirubicin—ovarian cancer	0.000213	0.000548	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000213	0.00162	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000212	0.00161	CbGpPWpGaD
Cyproterone acetate—Tension—Doxorubicin—ovarian cancer	0.000211	0.000541	CcSEcCtD
Cyproterone acetate—Vomiting—Paclitaxel—ovarian cancer	0.000211	0.000541	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—ovarian cancer	0.000209	0.000537	CcSEcCtD
Cyproterone acetate—Rash—Paclitaxel—ovarian cancer	0.000209	0.000536	CcSEcCtD
Cyproterone acetate—Dermatitis—Paclitaxel—ovarian cancer	0.000209	0.000536	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—ovarian cancer	0.000209	0.00159	CbGpPWpGaD
Cyproterone acetate—Syncope—Epirubicin—ovarian cancer	0.000208	0.000534	CcSEcCtD
Cyproterone acetate—Leukopenia—Epirubicin—ovarian cancer	0.000208	0.000533	CcSEcCtD
Cyproterone acetate—Headache—Paclitaxel—ovarian cancer	0.000208	0.000533	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000208	0.00158	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000207	0.00158	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Docetaxel—ovarian cancer	0.000207	0.000531	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000207	0.00157	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TTF1—ovarian cancer	0.000207	0.00157	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Epirubicin—ovarian cancer	0.000204	0.000524	CcSEcCtD
Cyproterone acetate—Cough—Epirubicin—ovarian cancer	0.000203	0.00052	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000202	0.00153	CbGpPWpGaD
Cyproterone acetate—Asthenia—Docetaxel—ovarian cancer	0.000202	0.000517	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000199	0.000512	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—ovarian cancer	0.000199	0.00151	CbGpPWpGaD
Cyproterone acetate—Pruritus—Docetaxel—ovarian cancer	0.000199	0.00051	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—ovarian cancer	0.000199	0.00051	CcSEcCtD
Cyproterone acetate—Agitation—Doxorubicin—ovarian cancer	0.000197	0.000507	CcSEcCtD
Cyproterone acetate—Nausea—Paclitaxel—ovarian cancer	0.000197	0.000505	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000197	0.0015	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000196	0.000504	CcSEcCtD
Cyproterone acetate—Discomfort—Epirubicin—ovarian cancer	0.000195	0.000501	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PGR—ovarian cancer	0.000194	0.00147	CbGpPWpGaD
Cyproterone acetate—Malaise—Doxorubicin—ovarian cancer	0.000194	0.000497	CcSEcCtD
Cyproterone acetate—Syncope—Doxorubicin—ovarian cancer	0.000193	0.000494	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—ovarian cancer	0.000192	0.000494	CcSEcCtD
Cyproterone acetate—Diarrhoea—Docetaxel—ovarian cancer	0.000192	0.000493	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.00019	0.00144	CbGpPWpGaD
Cyproterone acetate—Oedema—Epirubicin—ovarian cancer	0.00019	0.000486	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—ovarian cancer	0.000189	0.000485	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—NR5A1—ovarian cancer	0.000188	0.00143	CbGpPWpGaD
Cyproterone acetate—Cough—Doxorubicin—ovarian cancer	0.000187	0.000481	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000187	0.00142	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000187	0.00142	CbGpPWpGaD
Cyproterone acetate—Shock—Epirubicin—ovarian cancer	0.000186	0.000478	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Epirubicin—ovarian cancer	0.000186	0.000477	CcSEcCtD
Cyproterone acetate—Dizziness—Docetaxel—ovarian cancer	0.000186	0.000477	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Epirubicin—ovarian cancer	0.000186	0.000476	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000185	0.00141	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Epirubicin—ovarian cancer	0.000185	0.000475	CcSEcCtD
Cyproterone acetate—Skin disorder—Epirubicin—ovarian cancer	0.000184	0.000472	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000183	0.00139	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000183	0.00047	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000183	0.00139	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000183	0.00139	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—ovarian cancer	0.000183	0.00139	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—ovarian cancer	0.000182	0.00138	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—ovarian cancer	0.000182	0.00138	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000182	0.000466	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—ovarian cancer	0.000181	0.000464	CcSEcCtD
Cyproterone acetate—Anorexia—Epirubicin—ovarian cancer	0.000181	0.000464	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PARP1—ovarian cancer	0.00018	0.00137	CbGpPWpGaD
Cyproterone acetate—Vomiting—Docetaxel—ovarian cancer	0.000179	0.000458	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000179	0.00136	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000178	0.00135	CbGpPWpGaD
Cyproterone acetate—Rash—Docetaxel—ovarian cancer	0.000177	0.000455	CcSEcCtD
Cyproterone acetate—Hypotension—Epirubicin—ovarian cancer	0.000177	0.000454	CcSEcCtD
Cyproterone acetate—Dermatitis—Docetaxel—ovarian cancer	0.000177	0.000454	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000176	0.00134	CbGpPWpGaD
Cyproterone acetate—Headache—Docetaxel—ovarian cancer	0.000176	0.000452	CcSEcCtD
Cyproterone acetate—Oedema—Doxorubicin—ovarian cancer	0.000175	0.00045	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—ovarian cancer	0.000175	0.00133	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000173	0.00131	CbGpPWpGaD
Cyproterone acetate—Shock—Doxorubicin—ovarian cancer	0.000173	0.000443	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000172	0.00131	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000172	0.00131	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Doxorubicin—ovarian cancer	0.000172	0.000441	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000172	0.000441	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—ovarian cancer	0.000171	0.000439	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000171	0.0013	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Doxorubicin—ovarian cancer	0.00017	0.000437	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00017	0.000435	CcSEcCtD
Cyproterone acetate—Dyspnoea—Epirubicin—ovarian cancer	0.000169	0.000434	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000169	0.00128	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000169	0.00128	CbGpPWpGaD
Cyproterone acetate—Anorexia—Doxorubicin—ovarian cancer	0.000167	0.000429	CcSEcCtD
Cyproterone acetate—Nausea—Docetaxel—ovarian cancer	0.000167	0.000428	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—ovarian cancer	0.000167	0.000428	CcSEcCtD
Cyproterone acetate—Decreased appetite—Epirubicin—ovarian cancer	0.000165	0.000423	CcSEcCtD
Cyproterone acetate—Hypotension—Doxorubicin—ovarian cancer	0.000164	0.00042	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000164	0.00042	CcSEcCtD
Cyproterone acetate—Fatigue—Epirubicin—ovarian cancer	0.000163	0.000419	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000163	0.00124	CbGpPWpGaD
Cyproterone acetate—Constipation—Epirubicin—ovarian cancer	0.000162	0.000416	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000161	0.00123	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYTB—ovarian cancer	0.000161	0.00122	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—ovarian cancer	0.00016	0.00122	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000159	0.00121	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—ovarian cancer	0.000159	0.00121	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000157	0.0012	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000157	0.00119	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—ovarian cancer	0.000156	0.000401	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Epirubicin—ovarian cancer	0.000156	0.000401	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000155	0.00118	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000155	0.000398	CcSEcCtD
Cyproterone acetate—Dyspepsia—Doxorubicin—ovarian cancer	0.000154	0.000396	CcSEcCtD
Cyproterone acetate—Decreased appetite—Doxorubicin—ovarian cancer	0.000152	0.000391	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000151	0.000388	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—ovarian cancer	0.000151	0.000388	CcSEcCtD
Cyproterone acetate—Urticaria—Epirubicin—ovarian cancer	0.000151	0.000386	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—ovarian cancer	0.00015	0.000385	CcSEcCtD
Cyproterone acetate—Abdominal pain—Epirubicin—ovarian cancer	0.00015	0.000384	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—ovarian cancer	0.00015	0.000384	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000149	0.00114	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000148	0.00113	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ovarian cancer	0.000148	0.00112	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000147	0.00112	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000145	0.0011	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000145	0.0011	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Doxorubicin—ovarian cancer	0.000145	0.000371	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000143	0.000368	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000143	0.00109	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000142	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—YAP1—ovarian cancer	0.000141	0.00107	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPP1CC—ovarian cancer	0.000141	0.00107	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BRIP1—ovarian cancer	0.000141	0.00107	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.00014	0.00106	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.00014	0.00106	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Epirubicin—ovarian cancer	0.00014	0.000358	CcSEcCtD
Cyproterone acetate—Urticaria—Doxorubicin—ovarian cancer	0.000139	0.000357	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—ovarian cancer	0.000139	0.000356	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—ovarian cancer	0.000139	0.000356	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000139	0.00105	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000137	0.00104	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—ovarian cancer	0.000137	0.00104	CbGpPWpGaD
Cyproterone acetate—Asthenia—Epirubicin—ovarian cancer	0.000136	0.000349	CcSEcCtD
Cyproterone acetate—Pruritus—Epirubicin—ovarian cancer	0.000134	0.000344	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000132	0.001	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Epirubicin—ovarian cancer	0.00013	0.000333	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000129	0.000332	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000126	0.00096	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—ovarian cancer	0.000126	0.000323	CcSEcCtD
Cyproterone acetate—Dizziness—Epirubicin—ovarian cancer	0.000125	0.000322	CcSEcCtD
Cyproterone acetate—Pruritus—Doxorubicin—ovarian cancer	0.000124	0.000318	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—PGR—ovarian cancer	0.000123	0.000935	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000122	0.000926	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000121	0.000922	CbGpPWpGaD
Cyproterone acetate—Vomiting—Epirubicin—ovarian cancer	0.00012	0.000309	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—ovarian cancer	0.00012	0.000308	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.00012	0.000909	CbGpPWpGaD
Cyproterone acetate—Rash—Epirubicin—ovarian cancer	0.000119	0.000307	CcSEcCtD
Cyproterone acetate—Dermatitis—Epirubicin—ovarian cancer	0.000119	0.000306	CcSEcCtD
Cyproterone acetate—Headache—Epirubicin—ovarian cancer	0.000119	0.000305	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000117	0.000892	CbGpPWpGaD
Cyproterone acetate—Dizziness—Doxorubicin—ovarian cancer	0.000116	0.000298	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—PARP1—ovarian cancer	0.000114	0.00087	CbGpPWpGaD
Cyproterone acetate—Nausea—Epirubicin—ovarian cancer	0.000113	0.000289	CcSEcCtD
Cyproterone acetate—Vomiting—Doxorubicin—ovarian cancer	0.000111	0.000286	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—ovarian cancer	0.000111	0.000843	CbGpPWpGaD
Cyproterone acetate—Rash—Doxorubicin—ovarian cancer	0.000111	0.000284	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—ovarian cancer	0.00011	0.000283	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—ovarian cancer	0.00011	0.000282	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—YAP1—ovarian cancer	0.000107	0.000813	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—ovarian cancer	0.000104	0.000267	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—ovarian cancer	0.000104	0.000787	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.000103	0.000782	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000102	0.000779	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	9.91e-05	0.000753	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—ovarian cancer	9.58e-05	0.000728	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—YAP1—ovarian cancer	9.43e-05	0.000717	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PGR—ovarian cancer	9.34e-05	0.00071	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.33e-05	0.000709	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPP2R1A—ovarian cancer	9.28e-05	0.000705	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PARP1—ovarian cancer	8.68e-05	0.00066	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.21e-05	0.000624	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FASN—ovarian cancer	7.69e-05	0.000584	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A5—ovarian cancer	7.56e-05	0.000575	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC2A1—ovarian cancer	7.3e-05	0.000555	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.15e-05	0.000544	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—ovarian cancer	7.1e-05	0.00054	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPP2R1A—ovarian cancer	7.04e-05	0.000535	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1B1—ovarian cancer	7e-05	0.000532	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—ovarian cancer	6.57e-05	0.000499	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	6.21e-05	0.000472	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.18e-05	0.00047	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—ovarian cancer	5.77e-05	0.000438	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TYMS—ovarian cancer	5.66e-05	0.00043	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—ovarian cancer	5.39e-05	0.000409	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—ovarian cancer	4.99e-05	0.000379	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAV1—ovarian cancer	4.56e-05	0.000347	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.36e-05	0.000331	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—ovarian cancer	4.16e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—ovarian cancer	3.65e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK3—ovarian cancer	3.51e-05	0.000267	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—ovarian cancer	3.42e-05	0.00026	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—ovarian cancer	3.19e-05	0.000242	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—ovarian cancer	2.75e-05	0.000209	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK3—ovarian cancer	2.67e-05	0.000203	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—ovarian cancer	2.59e-05	0.000197	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—ovarian cancer	2.37e-05	0.00018	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—ovarian cancer	1.94e-05	0.000148	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—ovarian cancer	1.8e-05	0.000137	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—ovarian cancer	1.59e-05	0.000121	CbGpPWpGaD
